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Abstract
Purpose—We estimated the costs and effectiveness of state programs in the National Breast and 
Cervical Cancer Early Detection Program (NBCCEDP) based on the type of delivery structure.
Methods—Programs were classified into three delivery structures: (1) centralized, (2) 
decentralized, and (3) mixed. Centralized programs offer clinical services in satellite offices, but 
all other program activities are performed centrally. Decentralized programs contract with other 
entities to fully manage and provide screening and diagnostic services and other program 
activities. Programs with mixed service delivery structures have both centralized and decentralized 
features. Programmatic costs were averaged over a 3 year period (2006–2007, 2008–2009, and 
2009–2010). Effectiveness was defined in terms of the average number of women served over the 
3 years. We report costs per woman served by program activity and delivery structure and 
incremental cost effectiveness by program structure and by breast/cervical services.
Results—Average costs per woman served were lowest for mixed program structures (breast=
$225, cervical = $216) compared to decentralized (breast = cervical = $276) and centralized 
program structures (breast = $259, cervical = $251). Compared with decentralized programs, for 
each additional woman served, centralized programs saved costs of $281 (breast) and $284 
(cervical). Compared with decentralized programs, for each additional woman served, mixed 
programs added an additional $109 cost for breast but saved $1,777 for cervical cancer.
Conclusions—Mixed program structures were associated with the lowest screening and 
diagnostic costs per woman served and had generally favorable incremental costs relative to the 
other program structures.
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Introduction
As the largest cancer-screening program in the United States, the National Breast and 
Cervical Cancer Early Detection Program (NBCCEDP) serves as a learning laboratory for 
other national cancer and non-cancer prevention and control programs. The NBCCEDP’s 
organizational structure is complex; CDC funds states, tribes/tribal organizations, and US 
territories across the US and each grantee’s program has established a unique screening 
delivery system to serve their population of eligible women. Each of these programs uses 
one of the following three different service delivery mechanisms in their respective 
jurisdictions: (1) centralized, (2) decentralized, and (3) mixed [1]. Centralized programs 
offer clinical services in satellite offices, which may include local health departments that 
are not independent entities from the state health departments, but all other program 
activities are performed centrally (e.g., tracking and case management service). 
Decentralized programs, on the other hand, contract with local and regional health 
departments, primary care clinics (e.g., community health centers), private hospitals, or other 
healthcare facilities to fully manage and provide screening and diagnostic services and other 
program activities.
Programs with mixed service delivery structures have both centralized and decentralized 
features [2.] There is a great deal of variation among states with a mixed delivery structures 
and this variation depends upon the needs and capacity at the health department. Various 
activities of the program may be managed at the state health department while other 
activities are managed at district level or even in the providers’ offices. For example, some 
state health departments do their program enrollment through the provider offices, but have 
patient navigation and the billing controlled centrally at the state health department. Other 
programs contract with providers directly for clinical services such as Federally Qualified 
Health Centers.
NBCCEDP grantees selected their program structures for specific reasons and the delivery 
structure was not arbitrary or randomly assigned. The delivery structure for each grantee is 
based on the infrastructure of their health department system. States that function through 
health districts were more likely to have a decentralized program whereas states with 
internal infrastructure may centralize the entire program in the state health department.
In recent years, attention has been given to the estimated costs and effects of these delivery 
structures for cancer screening, diagnostic follow-up, and other program services. Because 
program resources reach only a fraction of eligible women, all other things equal, service 
delivery mechanisms that provide efficient allocation of resources are clearly desirable. Such 
service delivery mechanisms should enable programs to screen and serve optimal numbers 
of eligible populations. Currently, there is no information describing how the three service 
delivery structures used by NBCCEDP grantees impact costs and effectiveness. In this study, 
we assessed the costs and effectiveness of various delivery structures used to deliver 
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screening, diagnostic, and other program services in the NBCCEDP and examined how 
different types of service delivery structures affect the number of women served.
Methods
Cost assessment tool
To collect economic costs related to the NBCCEDP, we used a customized cost assessment 
tool (CAT). The development and testing of the CAT has been described previously [1, 3]. In 
brief, the CAT collected activity-based economic cost data from the programmatic 
perspective, regardless of the funding source used to pay those costs. A detailed protocol 
was used to guide the data collection at each of the 68 grantees funded at the time of data 
collection.
In the CAT, grantees reported costs for items such as staff time, materials purchased, and 
screening costs. For each line item, grantees were provided space to list up to three activities 
for which the resource was used. Each activity was selected from the following options: 
management, screening, case management, tracking and follow-up assessment, public 
education and outreach, professional education, coalition and partnership building, quality 
assurance and improvement, and surveillance and evaluation. For example, hours reported 
for a registered nurse may have been allocated to case management, professional education 
and quality assurance and improvement. Further, in the CAT, grantees were also required to 
report the relative focus of each activity on breast or cervical cancer in their programs.
We used the CAT to collect cost data for the 2006–2007, 2008–2009, and 2009–2010 
program fiscal years. Grantee activities and costs supported by all funding sources, including 
CDC, the state, and other organizations, were collected in the CAT and reported in this 
study. Five grantees (California, Hawaii, Maine, Michigan, and Minnesota) provided cost 
data for 2007–2008 rather than for 2009–2010. Because we analyzed average annual costs 
(see Statistical Analysis below), we retained these grantee’s programs in the analysis.
To ensure the accuracy of data collected with the CAT, we performed a series of data quality 
checks. We verified that all CAT modules were fully and accurately completed. We reviewed 
the submitted data to determine whether grantees reported their actual total expenditures for 
clinical (screening and diagnostic) procedures rather than their rates per procedure. We 
checked to ensure that grantees did not double-report cost data across modules. We also 
compared data across fiscal years to identify large, potentially erroneous, changes in 
reported costs. For grantees with incomplete or potentially inaccurate data, we resolved 
inconsistencies via e-mail and telephone calls and, in some cases, through revisions in the 
CAT.
Our final analysis sample included 147 program-years. We excluded tribes and territories 
because our preliminary analysis indicated that their cost structures were very different from 
those of the state programs. We also excluded six program-years in which total costs differed 
by more than 10% from adjusted annual funding due to data quality concerns. These six 
program-years represented 1 year of data from each of six different states: five of those 
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program-years were the first year of data collection (2006–2007) and one program-year was 
2008–2009.
Women served
Data on the numbers of women served were obtained from CDC’s Minimum Data Elements 
(MDE) and the CAT. The MDE collects patient-level clinical data that are associated with 
federal NBCCEDP funds, whereas the CAT collected clinical data on women screened with 
non-federal funds and in-kind contributions. The total number of women served included all 
women who were screened or who received diagnostic follow-up using either federal or non-
federal funds.
Statistical analysis
Program costs and the number of women served were averaged over time at the grantee level 
before analysis to obtain statistics for a representative year. Program costs for each activity 
were calculated by pooling all expenditures allocated to that activity. Activity costs per 
woman served were calculated by dividing activity costs by the number of women served. 
All costs in this analysis are presented in 2010 dollars. We report median activity costs per 
woman served by program delivery structure. We test the null hypothesis that delivery 
structure is independent of costs using a nonpara-metric k sample test on the equality of 
medians in unpaired data (Stata command “medians”; Stata Version 14.0, College Station, 
TX).
We examined the pseudo-incremental cost effectiveness of program delivery structure, 
defined as the difference in cost between two delivery structures divided by the difference in 
the number of women served. In cases in which a program structure is more expensive 
(higher cost) but also more effective (greater number of women served), incremental cost 
effectiveness can be calculated; this provides the cost effectiveness of one program structure 
relative to another. Activity costs were allocated to breast and cervical cancer-specific costs 
using the allocation for each activity reported in the CAT. We then aggregated the within-
program averages for overall program costs and women served by delivery structure. 
Average and incremental cost effectiveness ratios were calculated using these delivery 
structure totals.
Sensitivity analyses
We performed two sensitivity analyses related to our inclusion and exclusion criteria. First, 
we conducted the analysis excluding the program-years representing 2007–2008 instead of 
2008–2009 (CA, HI, ME, MI, and MN). Second, we conducted the analysis including the 
program-years in which total costs differed by more than 10% from adjusted annual funding.
Results
Across the 51 state programs (including Washington DC), ten were centralized, 17 were 
decentralized, and 24 were mixed (Fig. 1). Figure 2 reports median costs per woman served 
for each activity by program structure. Screening and diagnostic services had the highest 
median costs per woman served (from $131.84 for mixed programs to $152.57 for 
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centralized programs). The next highest median costs per woman served was for program 
management (from $14.98 for mixed programs to $32.99 for decentralized programs) and 
patient support/case management (from $10.88 for centralized programs to $30.71 
decentralized programs). Differences in median costs per woman served were largest for 
these activities and were significantly different from screening and diagnostic services (p = 
0.012) and program management (p = 0.012). Decentralized programs spent the most on 
program management. Mixed programs’ median screening and diagnostic service costs per 
woman served were approximately $20 lower than centralized and decentralized programs.
Table 1 presents the results of the pseudo-incremental cost-effectiveness analysis. 
Centralized programs are reported first because they served the smallest number of women, 
followed by the decentralized programs, and then the mixed programs. Compared with a 
base of centralized programs, decentralized programs incurred costs of $281 for each 
additional woman served for breast cancer and $284 for each additional woman served for 
cervical cancer. Compared with decentralized programs, mixed programs added an 
additional $109 for each additional woman served for breast cancer but saved $1,777 for 
each additional woman served for cervical cancer. In both sensitivity analyses (excluding the 
2007–2008 program-years and including the program-years in which total costs differed by 
more than 10% from adjusted annual funding) the results for average and incremental cost 
effectiveness were nearly identical to those reported Table 1, with estimates within a few 
dollars of the original analytic sample (available upon request).
Discussion
Our results indicate that program delivery structure was associated with the cost and 
effectiveness of services provided by NBCCEDP grantee programs. Mixed program 
structures were the most common among NBCCEDP grantees and they had the lowest 
screening and diagnostic costs per woman served. This is important, as programs were 
required to spend at least 60% of their funds on these activities during the time of this study. 
Screening and diagnostic costs were approximately five times higher than costs per woman 
served for the next highest cost activity (program management).
Programs with mixed structures served the most number of women annually. For breast 
cancer screening services, these program s also had the highest total costs. However, for 
cervical cancer screening services, programs with mixed structures actually served more 
women than decentralized programs at a lower cost.
These results could reflect the fact that a mixed program structure allows programs to 
specialize on specific activities for which they are the most efficient. M any mixed programs 
do not have local health departments that can deliver screening services. Thus, the most 
common activities to be outsourced are direct screening and follow-up services and billing 
support. There is heterogeneity across programs in the decision on which activities to keep 
within the program and which to decentralize.
We excluded tribes and territories from our analysis. Previous cost analyses of the 
NBCCEDP have also excluded cost data from tribes and territories for several reasons [1, 2, 
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4]. First, there are significant demographic and cultural differences between states, tribes, 
and territories [5]. Second, organizational factors that impact delivery of screening services 
are different among tribe and territory grantees of the NBCCEDP as compared to the states 
[6]. Lastly, including data from smaller tribe and territory grantees created instability in 
national estimates.
Our results give some understanding of the relative costs of these program structures. 
However, we have a small number of programs for some structures (e.g., only ten centralized 
program s). Furthermore, costs and the number of women served depend on many factors 
not included in this analysis. These include the population of eligible women in the 
catchment area, availability and costs of clinical and program staff, and other characteristics 
specific to the program ‘s target population [2, 7–9].
In addition, NBCCEDP grantees selected their program structures for specific reasons, and 
the delivery structure was not arbitrary or randomly assigned. The choice of delivery 
structure may be associated with other factors that affect cost effectiveness, creating 
confounding of the measured association. For example, the NBCCEDP has been shown to 
exhibit economies of scale, in which the average cost per woman served decreases as the 
number of women served increases [10]. If larger programs tend to choose a mixed delivery 
structure, this could lead to lower costs per woman served. Therefore, caution should be 
used in interpreting the results of this study.
Conclusion
A key decision for disease prevention and control programs is how to structure the delivery 
of health services. In the NBCCEDP, delivery structure was associated with average and 
incremental cost effectiveness of the state programs. In particular, a mixed delivery structure 
was associated with lower costs per woman served. The results are suggestive that a mixed 
structure, in which programs perform activities in which they have a comparative advantage 
and outsource all other activities, may be a promising approach to improve the efficiency of 
the programs. Programs would need to ensure that such a structure is feasible and 
appropriate given their own context.
Acknowledgments
The authors thank Wesley Crouse for his assistance in data collection.
Funding This study was funded by Contract No. 200-2002-00575 TO 06 and 200-2008-27958 TO 9 from the 
Centers for Disease Control and Prevention (CDC). The findings and conclusions in this report are those of the 
authors and do not necessarily represent the official position of the CDC.
References
1. Ekwueme DU, Gardner JG, Subramanian S, Tangka FK, Bapat B, Richardson LC (2008) Cost 
analysis of the National Breast and Cervical Cancer Early Detection Program: selected states, 2003 
to 2004. Cancer 112:626–635 [PubMed: 18157831] 
2. Subramanian S, Ekwueme DU, Gardner JG, Bapat B, Kramer C (2008) Identifying and controlling 
for program-level differences in comparative cost analysis: lessons from the economic evaluation of 
the National Breast and Cervical Cancer Early Detection Program. Eval Program Plan 31:136–144
Trogdon et al. Page 6
Cancer Causes Control. Author manuscript; available in PMC 2020 February 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
3. Subramanian S, Ekwueme DU, Gardner JG, Trogdon J (2009) Developing and testing a cost-
assessment tool for cancer screening programs. Am J Prev Med 37:242–247 [PubMed: 19666160] 
4. Ekwueme DU, Hall IJ, Richardson LC, Gardner JG, Royalty J, Thompson TD (2008) Estimating 
personal costs incurred by a woman participating in mammography screening in the National Breast 
and Cervical Cancer Early Detection Program. Cancer 113:592–601 [PubMed: 18536027] 
5. Miller JW, Plescia M, Ekwueme DU (2014) Public health national approach to reducing breast and 
cervical cancer disparities. Cancer 120(Suppl 16):2537–2539 [PubMed: 25099895] 
6. Espey DK, Wu XC, Swan J et al. (2007) Annual report to the nation on the status of cancer, 1975–
2004, featuring cancer in American Indians and Alaska Natives. Cancer 110:2119–2152 [PubMed: 
17939129] 
7. Ekwueme DU, Subramanian S, Trogdon JG et al. (2014) Cost of services provided by the National 
Breast and Cervical Cancer Early Detection Program. Cancer 120(Suppl 16):2604–2611 [PubMed: 
25099904] 
8. Subramanian S, Tangka FK, Ekwueme DU, Trogdon J, Crouse W, Royalty J (2015) Erratum to: 
explaining variation across grantees in breast and cervical cancer screening proportions in the NBC-
CEDP. Cancer Causes Control 26:697 [PubMed: 25929886] 
9. Subramanian S, Tangka FK, Ekwueme DU, Trogdon J, Crouse W, Royalty J (2015) Explaining 
variation across grantees in breast and cervical cancer screening proportions in the NBCCEDP. 
Cancer Causes Control 26:689–695 [PubMed: 25840557] 
10. Trogdon JG, Ekwueme DU, Subramanian S, Crouse W (2014) Econom ies of 0073cale in 
federally-funded state-organized public health programs: results from the National Breast and 
Cervical Cancer Early Detection Programs. Health Care Manag Sci 17:321–330 [PubMed: 
24326873] 
Trogdon et al. Page 7
Cancer Causes Control. Author manuscript; available in PMC 2020 February 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 1. 
NBCCEDP delivery structure
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Fig. 2. 
Median cost per woman served by program component and delivery structure (2010$) (The 
distribution of cost per program component excludes in-kind contributions. * indicate cost 
categories that are statistically significantly different across delivery structures at the 95% CI 
based on a nonparametric k sample test on the equality of medians in unpaired data)
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